DAISY
Live / Registered — Registered (as of 18 Aug 2026)
What this means for you
Registered since 18 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 98354562
- Registration number
- 8397643
- Mark type
- Word mark
- Filed
- 12 Jan 2024
- Published for opposition
- 30 Jun 2026
- Registered
- 18 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 18 Aug 2032 (grace period to 18 Feb 2033)
- Attorney of record
- MARK E. TETREAULT
Goods and services
- Class 005 — Pharmaceuticals: Disposable intradermal injectors sold pre-filled with medication, namely vaccines
Owner
- DEKA Research & Development Corp., Manchester, NH, US
- DEKA Research & Development Corp., Manchester, NH, US
- DEKA Research & Development Corp., Manchester, NH, US
Board proceedings on this mark
- Ex Parte Appeal No. 98354562 — DEKA Research & Development Corp., filed 16 May 2025 (Terminated)
Prosecution history
- 18 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 30 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jun 2026 — PUBLISHED FOR OPPOSITION
- 24 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Jun 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Jun 2026 — EXAMINER'S AMENDMENT ENTERED
- 04 Jun 2026 — EXAMINERS AMENDMENT E-MAILED
- 04 Jun 2026 — EXAMINERS AMENDMENT -WRITTEN
- 02 Jun 2026 — EXPARTE APPEAL TERMINATED
- 19 Mar 2026 — EX PARTE APPEAL-REFUSAL AFFIRMED
- 04 Nov 2025 — NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
- 04 Nov 2025 — EXAMINERS STATEMENT E-MAILED
- 04 Nov 2025 — EXAMINERS STATEMENT - COMPLETED
- 11 Sept 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY